Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
A large basket of COVID-19 vaccine candidates is important: Renu Swarup
She said the vaccines that are being developed indigenously are on different platforms and each has its own benefits and…
AYUSH stakeholders should focus on R&D, follow regulatory pathways: Piyush Goyal
He assured support to the AYUSH department for framing guidelines and standardisation processes to bring better acceptability for…
Three big-ticket deals contributed 69 per cent of total deal value in November 2020
The healthcare industry reported 91 VC deals worth $3.3 billion in November 2020
Moderna to supply six million doses of COVID-19 vaccine to Israel
The company has already initiated the rolling regulatory review process with the Ministry of Health in Israel
Rising trends in combination drugs markets
Apurve Mehra, Founder, Biogetica opines that natural medicine can serve as an effective adjunct for almost every single ailment…
COVID-19 vaccination drive will commence as soon as scientists give go ahead: PM Modi
Healthcare workers involved in treating coronavirus patients, frontline workers and old people suffering from serious conditions…
Zydus gets DCGI approval to commence Phase III clinical trials with Pegylated Interferon alpha-2b
In Phase II clinical trials, Pegylated Interferon alpha – 2b increased viral reduction and reduced the need for supplemental…
Indifi forays into pharma segment along with Marg ERP
Indifi will be extending its credit line solution to pharma distributors and local chemists for managing their working capital…
Merck KGaA signs deal with Artios Pharma for cancer drugs research
Artios will receive $30 million in up-front and near-term payments, plus double-digit option fees and up $860 million total…
Inovio signs deal with Japan’s Kaneka for COVID-19 vaccine manufacturing
Inovio has also signed manufacturing deals with medical device maker Thermo Fisher Scientific among others